Cargando…

Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture models

Current therapeutic approaches have met limited clinical success for glioblastoma multiforme (GBM). Since GBM harbors genomic alterations in cyclin-dependent kinases (CDKs), targeting these structures with specific inhibitors (CDKis) is promising. Here, we describe the antitumoral potential of selec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riess, Christin, Koczan, Dirk, Schneider, Björn, Linke, Charlotte, del Moral, Katharina, Classen, Carl Friedrich, Maletzki, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961149/ https://www.ncbi.nlm.nih.gov/pubmed/33723248 http://dx.doi.org/10.1038/s41420-021-00423-1

Ejemplares similares

HGG-07. CYCLIN-DEPENDENT KINASES AS TARGET STRUCTURES FOR CANCER THERAPY – A COMPARATIVE IN VITRO ANALYSIS ON PATIENT-DERIVED GLIOBLASTOMA CELL CULTURE MODELS
por: Riess, Christin, et al.
Publicado: (2020)

Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?
por: Riess, Christin, et al.
Publicado: (2020)

HGG-13. Combined CDK inhibition and arginine-deprivation as targeted therapy for arginine-auxotrophic glioblastoma multiforme cells
por: Riess, Christin, et al.
Publicado: (2022)

Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells
por: Riess, Christin, et al.
Publicado: (2022)

The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C
por: Linke, Charlotte, et al.
Publicado: (2023)

Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib
por: Riess, Christin, et al.
Publicado: (2020)

The Individual Effects of Cyclin-Dependent Kinase Inhibitors on Head and Neck Cancer Cells—A Systematic Analysis
por: Schoenwaelder, Nina, et al.
Publicado: (2021)

Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma
por: William, Doreen, et al.
Publicado: (2018)

EVI1 exerts distinct roles in AML via ERG and cyclin D1 promoting a chemoresistant and immune-suppressive environment
por: Masamoto, Yosuke, et al.
Publicado: (2022)

Establishment and Characterization of Primary Glioblastoma Cell Lines from Fresh and Frozen Material: A Detailed Comparison
por: Mullins, Christina Susanne, et al.
Publicado: (2013)

The miR-183/96/182 cluster is upregulated in glioblastoma carrying EGFR amplification
por: Schneider, Björn, et al.
Publicado: (2022)

Amplification of the EGFR gene can be maintained and modulated by variation of EGF concentrations in in vitro models of glioblastoma multiforme
por: William, Doreen, et al.
Publicado: (2017)

USP5 Sustains the Proliferation of Glioblastoma Through Stabilization of CyclinD1
por: Li, Gen, et al.
Publicado: (2021)

PD-L1 Expression Fluctuates Concurrently with Cyclin D in Glioblastoma Cells
por: Tufano, Martina, et al.
Publicado: (2021)

Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies
por: William, Doreen, et al.
Publicado: (2017)

Tetracenomycin X Exerts Antitumour Activity in Lung Cancer Cells through the Downregulation of Cyclin D1
por: Qiao, Xinran, et al.
Publicado: (2019)

Kinase independent oncogenic cyclin D1
por: Casimiro, Mathew C., et al.
Publicado: (2015)

Regulation of Glioblastoma Progression by Cord Blood Stem Cells Is Mediated by Downregulation of Cyclin D1
por: Velpula, Kiran Kumar, et al.
Publicado: (2011)

Deciphering the binding behavior of flavonoids to the cyclin dependent kinase 6/cyclin D complex
por: Zhang, Jingxiao, et al.
Publicado: (2018)

Early milk-feeding regimes in calves exert long-term effects on the development of ovarian granulosa cells
por: Röttgen, Volker, et al.
Publicado: (2023)

Cyclin D1 goes metabolic: Dual functions of cyclin D1 in regulating lipogenesis
por: Knudsen, Karen E.
Publicado: (2012)

Cyclin D1 mediated by the nuclear translocation of nuclear factor kappa B exerts an oncogenic role in lung cancer
por: Wang, Xin, et al.
Publicado: (2022)

Let-7b expression determines response to chemotherapy through the regulation of Cyclin D1 in Glioblastoma
por: Guo, Yong, et al.
Publicado: (2013)

Cyclin-Dependent Kinase Inhibitors in Hematological Malignancies—Current Understanding, (Pre-)Clinical Application and Promising Approaches
por: Richter, Anna, et al.
Publicado: (2021)

Characterization of D-Cyclin Proteins in Hematolymphoid Neoplasms: Lack of Specificity of Cyclins D2 and D3 Expression in Lymphoma Subtypes
por: Metcalf, Ryan A, et al.
Publicado: (2010)

Cyclin K and cyclin D1b are oncogenic in myeloma cells
por: Marsaud, Véronique, et al.
Publicado: (2010)

25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 exert distinct effects on human skeletal muscle function and gene expression
por: Hassan-Smith, Zaki K., et al.
Publicado: (2017)

D-Type Cyclins in Development and Disease
por: Saleban, Mostafa, et al.
Publicado: (2023)

MicroRNA-16 Inhibits Glioblastoma Growth in Orthotopic Model by Targeting Cyclin D1 and WIP1
por: Wang, Heng, et al.
Publicado: (2020)

Clinical Correlation and Role of Cyclin D1 Expression in Glioblastoma Patients: A Study From North India
por: Jaiswal, Mamta, et al.
Publicado: (2022)

Embryonic Expression and Function of the Xenopus Ink4d Cyclin D-Dependent Kinase Inhibitor
por: Doherty, Joanne R., et al.
Publicado: (2014)

PRMT6 activates cyclin D1 expression in conjunction with the transcription factor LEF1
por: Schneider, Lucas, et al.
Publicado: (2021)

Caenorhabditis elegans Cyclin D/CDK4 and Cyclin E/CDK2 Induce Distinct Cell Cycle Re-Entry Programs in Differentiated Muscle Cells
por: Korzelius, Jerome, et al.
Publicado: (2011)

Concomitant Presence of p16/Cyclin‐dependent Kinase 4 and Cyclin D/Cyclin‐dependent Kinase 4 omplexes in LNCaP Prostatic Cancer Cell Line
por: Itoh, Noriyuki, et al.
Publicado: (1997)

Cyclin D1 and D3 expression in melanocytic skin lesions
por: Alekseenko, Ana, et al.
Publicado: (2010)

Cyclin D1 Induces Chromosomal Instability
por: Casimiro, Mathew C., et al.
Publicado: (2012)

Cyclin D1 expression in prostate carcinoma
por: Pereira, R.A., et al.
Publicado: (2014)

Role of cyclin D1 in breast carcinoma
por: Mohammadizadeh, Fereshteh, et al.
Publicado: (2013)

Activation of cyclin D1-related kinase in human lung adenocarcinoma
por: Igarashi, K, et al.
Publicado: (1999)

Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients
por: Bahnassy, Abeer A, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_sqttm3kj4br5kmbho7puiu091l